Table 1.
Demographics.
| Demographics | Target/hormone therapy (N = 80) | Immunotherapy (N = 16) | Chemotherapy (N = 63) | Hematology (N = 41) | Overall (N = 200) |
|---|---|---|---|---|---|
| Sex, n (%) | |||||
| Female | 71 (88.8) | 4 (25.0) | 43 (68.3) | 17 (41.5) | 135 (67.5) |
| Male | 9 (11.2) | 12 (75.0) | 20 (31.7) | 24 (58.5) | 65 (32.5) |
| Age, years | |||||
| Mean (SD) | 59.8 (12.2) | 68.3 (8.09) | 60.0 (13.2) | 61.2 (11.5) | 60.8 (12.3) |
| Median (range) | 60.0 (31.0-86.0) | 69.5 (56.0-84.0) | 61.0 (26.0-88.0) | 63.0 (25.0-79.0) | 62.0 (25.0-88.0) |
| BMI | |||||
| Mean (SD) | 25.7 (4.72) | 27.0 (4.13) | 25.5 (5.19) | 25.2 (3.88) | 25.6 (4.66) |
| Median (range) | 25.3 (17.8-40.0) | 26.9 (19.7-34.5) | 24 (18.9-44.8) | 24.4 (17.1-35.5) | 25.0 (17.1-44.8) |
| Missing, n (%) | 0 (0) | 0 (0) | 3 (4.8) | 2 (4.9) | 5 (2) |
| ECOG score, n (%) | |||||
| 0 | 74 (92.5) | 11 (68.8) | 48 (76.2) | 38 (92.7) | 171 (85.5) |
| 1 | 6 (7.5) | 5 (31.2) | 13 (20.6) | 3 (7.3) | 27 (13.5) |
| 2 | 0 (0) | 0 (0) | 1 (1.6) | 0 (0) | 1 (0.5) |
| Missing | 0 (0) | 0 (0) | 1 (1.6) | 0 (0) | 1 (0.5) |
| Autoimmune disease, n (%) | 4 (5.0) | 0 (0) | 1 (1.6) | 3 (7.3) | 8 (4.0) |
| Kidney disease, n (%) | 2 (2.5) | 1 (6.2) | 5 (7.9) | 1 (2.4) | 9 (4.5) |
| Hypertension, n (%) | 20 (25.0) | 4 (25.0) | 22 (34.9) | 8 (19.5) | 54 (27.0) |
| Diabetes, n (%) | 3 (3.8) | 2 (12.5) | 10 (15.9) | 5 (12.2) | 20 (10.0) |
| Coronary disease, n (%) | 5 (6.2) | 2 (12.5) | 10 (15.9) | 7 (17.1) | 24 (12.0) |
| Smoking status, n (%) | |||||
| Current smoker (all tobacco) | 5 (6.2) | 1 (6.2) | 5 (7.9) | 2 (4.9) | 13 (6.5) |
| Former smoker (all tobacco) | 21 (26.2) | 11 (68.8) | 21 (33.3) | 18 (43.9) | 71 (35.5) |
| Nonsmoker | 51 (63.8) | 3 (18.8) | 29 (46.0) | 21 (51.2) | 104 (52.0) |
| Missing | 3 (3.8) | 1 (6.2) | 8 (12.7) | 0 (0) | 12 (6.0) |
| Stage, n (%) | |||||
| I | 20 (25.0) | 0 (0) | 6 (9.5) | NA | 26 (16.4)a |
| II | 17 (21.2) | 2 (12.5) | 6 (9.5) | NA | 25 (15.7)a |
| II | 2 (2.5) | 0 (0) | 0 (0) | NA | 2 (1.2)a |
| III | 6 (7.5) | 2 (12.5) | 6 (9.5) | NA | 14 (8.8)a |
| IV | 33 (41.2) | 12 (75.0) | 42 (66.7) | NA | 87 (54.7)a |
| Missing | 2 (2.5) | 0 (0) | 3 (4.8) | NA | 46 (28.9)a |
BMI, body mass index; ECOG, Eastern Cooperative Oncology Group; NA, not applicable; SD, standard deviation.
a
Percentage of total of patient with solid tumor.